Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar;43(3):205-208.
doi: 10.1007/s40261-023-01250-1. Epub 2023 Mar 1.

A Fatal Case of Bictegravir-Induced Fulminant Hepatic Failure

Affiliations
Case Reports

A Fatal Case of Bictegravir-Induced Fulminant Hepatic Failure

Jacob Louis Sanchez et al. Clin Drug Investig. 2023 Mar.
No abstract available

PubMed Disclaimer

References

    1. Spagnuolo V, Castagna A, Lazzarin A. Bictegravir. Curr Opin HIV. AIDS. 2018;13:326–33. https://doi.org/10.1097/COH.0000000000000468 . - DOI
    1. Wohl D, Clarke A, Maggiolo F, Garner W, Laouri M, Martin H, et al. Patient-reported symptoms over 48 weeks among participants in randomized, double-blind, phase III non-inferiority trials of adults with HIV on co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus co-formulated abacavir, dolutegravir, and lamivudine. Patient. 2018;11:561–73. https://doi.org/10.1007/s40271-018-0322-8. - DOI - PubMed - PMC
    1. Rolle C-PM, Nguyen V, Patel K, Cruz D, Hinestrosa F, DeJesus E. 1012. Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected virologically-suppressed older adults in a real-world setting. Open Forum Infect Dis. 2020;7:S534–5. doi: https://doi.org/10.1093/OFID/OFAA439.1198 .
    1. Nolan NS, Adamson S, Reeds D, O’Halloran JA: Bictegravir-based antiretroviral therapy-associated accelerated hyperglycemia and diabetes mellitus. Open Forum Infect Diss. 2021;8. doi: https://doi.org/10.1093/OFID/OFAB077
    1. Senneker T, Tseng A. An update on neuropsychiatric adverse effects with second-generation integrase inhibitors and nonnucleoside reverse transcriptase inhibitors. Curr Opin HIV AIDS. 2021;16:309–20. https://doi.org/10.1097/COH.0000000000000705 . - DOI - PubMed

MeSH terms

LinkOut - more resources